9. M. B. Yunus, G. S. Holt, A. T. Masi and J. C. Aldag. 1988. Fibromyalgia syndrome among the elderly. Comparison with younger patients. J Am Geriatr Soc 36(11):987–995.

10. D. H. Reiffenberger and L. H. Amundson. 1996. Fibromyalgia syndrome: a review. Am Fam Phys 53(5):1698–1712.

11. L. H. Sigal, D. J. Chang and V. Sloan. 1998. 18 tender points and the “18 wheeler” sign: clues to the diagnosis of fibromyalgia. JAMA 279(6):434.

12. D. G. Simons, J. G. Travell and L. S. Simons. 1999. Travell and Simons’ Myofascial Pain and Dysfunction: The Trigger Point Manual, Second edition. Baltimore: Williams and Wilkins, p. 17.

13. T. L Yaksh, X. Y. Hua, I. Kalcheva, N. Nozaki-Taguchi and M. Marsala. 1999. The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci 96(14):7680–7686.

14. Yunus, M. B., M. A. Kahn, K. K. Rawlings, J. R. Green, J. M. Olson and S. Shah. 1999. Genetic linkage analysis of multicase families with fibromyalgia syndrome. J Rheumatol 26(2):408–412.

15. M. J. Pellegrino, G. W. Waylonis and A. Sommer. 1989. Familial occurrence of primary fibromyalgia. Arch Phys Med Rehabil 70(1):61–63.

16. R. W. Simms. 1998. Fibromyalgia is not a muscle disorder. Am J Med Sci 315(6):346–350.

17. F. Wolfe, J. Anderson, D. Harkness, R. M. Bennett, X. J. Caro, D. L. Goldenberg, I. J. Russel and M. B. Yunus. 1997. Health status and disease severity of fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum 40(9):1571–1579.

18. R. D. Gerwin. 1999. Differential diagnosis of myofascial pain syndrome and fibromyalgia. J Musculoskel Pain 7(1–2):209–215.

19. Simons, J. G., D. G. Travell, and L. S. Simons. 1999. Op. cit., p.18.

20. B. Evengard, C. G. Nilsson, G. Lindh, L. Lindquist, P. Eneroth, S. Fredrikson, L. Terenius and K. G. Henriksson. 1998. Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 78(2):153–155.

21. L. J. Crofford. 1998. Neuroendocrine findings and patients with fibromyalgia. J Musculoskel Pain 6(3):69.

22. I. J. Russell. 1998. Op. cit.

23. K. P. White, M. Speechley, M. Harth and T. Ostbye. 1999. The London Fibromyalgia Epidemiology Study: Comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 26(7):1577–1585.

24. M. Soppi and E. Beneforti. 1999. Muscular pain in some rheumatic diseases. J Musculoskel Pain 7(1–2):225–229.

25. K. G. Henriksson. 1999. Is fibromyalgia a distinct clinical entity? Pain mechanisms in fibromyalgia syndrome. A myologist’s view. Baillieres Best Pract Res Clin Rheumatol 13(3):455–461.

26. J. Sorensen, A. Bengtsson, J. Ahlner, K. G. Henriksson, L. Ekselius and M. Bengtsson. 1997. Fibromyalgia—are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 24(8):1615–1621.

27. J. Eisinger, D. Starlanyl, F. Blotman, L. Bueno, E. Houvenagle, R. Juvin, P. Kaminsky, K. Lawson, X. Le Loet, J. Lowe, P. Manesse, etal. 2000. [Protocoled ’ informaionsan on y mesur lesfibromy algiques.] Med i cine du sud-est Lyon Mediterranee Medical. 1:9-11. [French]

28. I. H Wittrup, A. Wiik and B. Danneskiold-Samsoe. 1999. Antibody profile in patients with fibromyalgia compared to healthy controls. J Musculoskel Pain 7(1–2):273–277.

29. M. B. Yunus, F. X. Hussey and J. C. Aldag. 1993. Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study. J. Rheumatol 20(9):1557–1560.